全文获取类型
收费全文 | 22325篇 |
免费 | 1677篇 |
国内免费 | 974篇 |
专业分类
耳鼻咽喉 | 478篇 |
儿科学 | 358篇 |
妇产科学 | 584篇 |
基础医学 | 1573篇 |
口腔科学 | 445篇 |
临床医学 | 1834篇 |
内科学 | 2391篇 |
皮肤病学 | 235篇 |
神经病学 | 423篇 |
特种医学 | 1497篇 |
外国民族医学 | 23篇 |
外科学 | 3580篇 |
综合类 | 3832篇 |
现状与发展 | 1篇 |
预防医学 | 652篇 |
眼科学 | 109篇 |
药学 | 958篇 |
4篇 | |
中国医学 | 136篇 |
肿瘤学 | 5863篇 |
出版年
2024年 | 35篇 |
2023年 | 211篇 |
2022年 | 432篇 |
2021年 | 669篇 |
2020年 | 690篇 |
2019年 | 638篇 |
2018年 | 627篇 |
2017年 | 589篇 |
2016年 | 744篇 |
2015年 | 739篇 |
2014年 | 1201篇 |
2013年 | 1029篇 |
2012年 | 1051篇 |
2011年 | 1308篇 |
2010年 | 1164篇 |
2009年 | 1265篇 |
2008年 | 1316篇 |
2007年 | 1499篇 |
2006年 | 1401篇 |
2005年 | 1190篇 |
2004年 | 1060篇 |
2003年 | 930篇 |
2002年 | 846篇 |
2001年 | 832篇 |
2000年 | 642篇 |
1999年 | 475篇 |
1998年 | 431篇 |
1997年 | 373篇 |
1996年 | 270篇 |
1995年 | 211篇 |
1994年 | 202篇 |
1993年 | 134篇 |
1992年 | 122篇 |
1991年 | 100篇 |
1990年 | 76篇 |
1989年 | 50篇 |
1988年 | 50篇 |
1987年 | 43篇 |
1986年 | 54篇 |
1985年 | 50篇 |
1984年 | 34篇 |
1983年 | 34篇 |
1982年 | 51篇 |
1981年 | 19篇 |
1980年 | 23篇 |
1979年 | 21篇 |
1978年 | 16篇 |
1977年 | 13篇 |
1976年 | 5篇 |
1975年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
171.
目的:探讨HPV与小儿喉乳状瘤发病及发展的相关性。方法:采用免疫组化方法检测46例小儿喉乳头状瘤96次手术的肿瘤组织及其HPV表达,另取8例正常小儿及成人的喉黏膜,10例成人喉乳头状瘤作对照,结果:小和和成人的正常喉黏膜无HPV表达,成人喉乳头状瘤2例有HPV表达,46例96人次小儿喉乳头状瘤,其中33例61人次肿瘤组织中有HPV表达,且与肿瘤的复发频率呈正相关。结论HPV在小儿喉乳头状瘤的发生发展过程中起重要作用。 相似文献
172.
血管内皮细胞生长因子及其受体在大肠癌组织中的表达 总被引:3,自引:0,他引:3
目的观察血管内皮生长因子(VEGF)及其受体(KDR)在大肠癌组织中的表达情况。方法利用免疫组化SABC 法检测80例大肠癌组织及10例正常大肠组织中的VEGF及KDR的表达。结果VEGF染色性物质主要位于肿瘤细胞 膜及胞浆,KDR染色性物质主要位于癌组织及癌组织旁的血管内皮细胞上,大肠癌组织中VEGF和KDR的表达阳性 率显著高于正常对照组织(P<0.01),VEGF和KDR的表达与肿瘤的分化程度及Dukes分期密切相关(P<0.05),与病理 分型无关(P>0.05)。结论VEGF和KDR在大肠癌的发生和发展中起着重要作用,可反映大肠癌的恶性程度和进展情 况,并作为预后的指标。 相似文献
173.
目的探讨多西他赛+卡铂联合曲妥珠单抗(TCH)方案对早期人表皮生长因子受体2(HER2)阳性乳腺癌的新辅助治疗效果。方法回顾性分析2013年1月至2018年12月北京大学第一医院乳腺疾病中心经治的522例早期HER2阳性乳腺癌患者的临床资料,占同期收治早期浸润性乳腺癌患者的21.80%(522/2 394)。其中113例接受TCH方案进行新辅助治疗,年龄[M(QR)]52(13)岁(范围:23~69岁)。记录TCH方案新辅助治疗后病理完全缓解(pCR,ypT0N0M0期)的例数,采用Miller-Payne标准进行病理学评价。采用Kaplan-Meier法计算无病生存率和总体生存率,采用Log-rank检验比较组间生存差异。结果接受曲妥珠单抗规范治疗患者(294例)的无病生存率优于未规范治疗患者(177例)(84.4%比72.4%,χ2=4.095,P=0.046)。发生3~4级不良反应的患者占全部患者的15.9%(18/113),包括3~4级中性粒细胞减少12例,腹泻6例。31例患者获得pCR(ypT0N0M0),pCR率为27.4%(31/113)。pCR患者与非pCR患者的无病生存率和总体生存率无差异(91.8%比85.0%,92.5%比90.5%,P值均>0.05)。病理学评价为G4~5的患者无病生存率优于G1~3患者(89.6%比81.5%,χ2=5.340,P=0.021),而总体生存率的差异无统计学意义(91.4%比89.1%,χ2=1.008,P=0.315)。结论早期HER2阳性乳腺癌采用TCH方案行新辅助治疗的效果较好,新辅助治疗后病理学评价为G4~5的患者的无病生存率更高。 相似文献
174.
BackgroundThe phase 3 NCT00793962 trial demonstrated that postmastectomy hypofractionated radiation therapy (HFRT) was noninferior to conventional fractionated radiation therapy (CFRT) in patients with high-risk breast cancer. This study assessed the cost-effectiveness of postmastectomy HFRT vs CFRT based on the NCT00793962 trial.MethodsA Markov model was adopted to synthesize the medical costs and health benefits of patients with high-risk breast cancer based on data from the NCT00793962 trial. Main outcomes were discounted lifetime costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratio (ICER). We employed a time-dependent horizon from Chinese, French and USA payer perspectives. Model robustness was evaluated with one-way and probabilistic sensitivity analyses.ResultsPatients receiving CFRT versus HFRT gained an incremental 0.0163 QALYs, 0.0118 QALYs and 0.0028 QALYs; meanwhile an incremental cost of $2351.92, $4978.34 and $8812.70 from Chinese, French and USA payer perspectives, respectively. Thus CFRT versus HFRT yielded an ICER of $144,281.47, $420,636.10 and $3,187,955.76 per QALY from Chinese, French and USA payer perspectives, respectively. HFRT could maintain a trend of >50% probabilities of cost-effectiveness below a willingness-to-pay (WTP) of $178,882.00 in China, while HFRT was dominant relative to CFRT, regardless of the WTP values in France and the USA. Sensitivity analyses indicated that the ICERs were most sensitive to the parameters of overall survival after radiotherapy.ConclusionsPostmastectomy HFRT could be used as a cost-effective substitute for CFRT in patients with high-risk breast cancer and should be considered in appropriately selected patients. 相似文献
175.
《Diagnostic Histopathology》2023,29(9):427-430
Pancreatic solid pseudopapillary neoplasm (SPN) is a rare low grade malignant tumour. Distinguishing this entity from other pancreatic neoplasms is critical for therapeutic decision making and prognostication. It predominantly affects young female patients <40 years of age, with excellent clinical outcome following surgical removal. The gold standard diagnostic test is cytopathological or histopathological assessment of fine needle aspirate. There are two main difficulties with this. First, SPN can present with morphological and immunohistochemical appearances that can closely mimic other pancreatic tumours, in particular, pancreatic neuroendocrine tumour (NET). Second, the amount of diagnostic material from fine needle aspiration can be limited. Here, we present a cytopathological case with both challenges during the pre-operative investigation of SPN. The case exemplifies the importance of combining morphological features with a targeted panel of immunohistochemistry to arrive at the diagnosis. 相似文献
176.
《Diagnostic Histopathology》2023,29(8):380-385
Interpretation of fine needle aspiration (FNA) material from salivary gland lesions has high interobserver variability due to the heterogenous and overlapping cytological features of various lesions. For this reason, second opinion consultation may play an important role in guiding appropriate clinical management for challenging cases. We aimed to report our experience with salivary gland cytology consultation cases at our academic center. Consecutive salivary gland FNA cases received from outside institutions for second opinion consultation between 2013 and 2022 were reviewed. Cases were divided into true consults (diagnostic assistance sought) or confirming consults (reviewed by in-house cytopathologists for patients being transferred to our institution for treatment). All diagnoses were re-classified using the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC). Discordance between reclassified consult diagnostic categories and preliminary diagnostic categories was recorded. Consultation resulted in a change in the diagnostic category in 15% of confirming and 18% of true consult cases. The overall distribution of diagnostic categories provided by outside pathologists was similar to consult diagnoses. Only 4 (5.4%) confirming and 3 (5.5%) true consult cases had major diagnostic discrepancies, which may impact the clinical treatment. Moderate interobserver variability is often expected with salivary gland FNA. However, in our consultation practice, we found a relatively high degree of concordance between submitting and consult diagnoses utilizing the MSRSGC. 相似文献
177.
178.
《The surgeon》2021,19(6):e549-e558
BackgroundNon-operative management is often the treatment of choice in cases of complicated appendicitis and routine interval appendectomy is not usually recommended. Actually, recent studies show an alarming number of appendiceal neoplasms following interval appendectomy. The aim of this study is to evaluate the prevalence of appendiceal neoplasms and their histological types after interval appendectomy for complicated appendicitis in adults.MethodsA comprehensive literature search of the PubMed, Scopus and Web of Science databases was conducted according to the PRISMA statement. Studies reporting appendiceal neoplasm rates after interval appendectomy and histopathological characteristics were included. The most recent World Health Organization (WHO) classification of malignant tumours was considered. A pooled prevalence analysis for both prevalence and pathology was performed.ResultsA total of eight studies was included: seven retrospective series and one randomized controlled trial. The pooled prevalence of neoplasms after interval appendectomy was 11% (95% CI 7–15; I2 = 37.5%, p = 0.13). Appendiceal mucinous neoplasms occurred in 43% (95% CI 19–68), adenocarcinoma in 29% (95% CI 6–51), appendiceal neuroendocrine neoplasm in 21% (95% CI 6–36), globet cell carcinoma in 13% (95% CI -2-28), adenoma or serrated lesions in 20% (95% CI -0-41) of cases.ConclusionThe risk of appendiceal neoplasm in patients treated with interval appendectomy for complicated appendicitis is 11%; mucinous neoplasm is the most common histopathological type. Further studies should investigate this association in order to clarify the biological pathway and clinical implications. 相似文献
179.
180.
Introduction:Prostate-specific antigen (PSA) kinetic patterns during neoadjuvant androgen deprivation therapy have been shown to predict unfavorable long-term outcomes.Objective:To investigate the effect of testosterone escape (TE) on these kinetic patterns, as this had not been previously reported.Methods:There were 50 consecutive prostate cancer patients who received 6 months of triptorelin prior to definitive radiotherapy (RT). Testosterone and PSA levels were measured at baseline and every 6 weeks. Clinical factors were tested for their ability to predict for TE and unfavorable PSA kinetic patterns. The effects of TE, at both 1.7 and 0.7 nmol/L levels, were analyzed.Results:TE occurred in at least one reading for 14% and 34% of the patients at the 1.7 and 0.7 nmol/L levels, respectively. No baseline factors predicted TE. The median PSA halving time was 25 days and the median pre-RT PSA level was 0.55 ng/mL. The only factor significantly associated with a higher pre-RT PSA level was a higher baseline PSA level. The only factor that significantly predicted a longer PSA halving time was TE at the 1.7 nmol/L level.Conclusions:TE and higher baseline PSA levels may adversely affect PSA kinetics and other outcomes for patients undergoing neoadjuvant hormone therapy prior to radiotherapy. Studies investigating the tailoring of neoadjuvant therapy by extending the duration in those patients with a higher baseline PSA level or by the addition of anti-androgens in those demonstrating TE, should be considered. 相似文献